Fixed Income Fallen angels – What is UBS-AM's view?

What is the impact on credit markets?

27 Apr 2020

Fixed income outlook Credit downgrades have increased

Amid the COVID-19 pandemic, the number of bonds that have actually been downgraded to high yield from investment grade (fallen angels) and the number that currently have a rating of BBB-, the last notch within investment grade, have both risen dramatically as ratings agencies assess the impact of the crisis on corporate balance sheets.

Fixed income outlook The economic backdrop

The unprecedented measures taken by governments across the world aimed at slowing the spread of COVID-19 has significantly impacted economic activity. Prior to the emergence of this pandemic, much had been publicized about the re-leveraging and general deterioration in quality that was occurring in high grade corporates. For example net leverage, as represented by Net Debt to EBITDA ratio had increased from 1.1 in 2011 to 1.9 in 2019 in US corporates according to data from Morgan Stanley. Additionally, the lowest quality tier of the high grade debt universe for example bonds rated BBB, had steadily increased from 30% of the overall market at the end of the 2008/09 financial crisis to roughly 50% today as the chart shows.

Although credit rating agencies have selectively downgraded a number of issuers from investment grade (IG) to high yield (HY) over the past few years, the focus was often on borrowers in a handful of sectors such as energy and metals and mining. What seemed to be missing was a catalyst that would trigger a broad based wave of so-called "’fallen angels’, a term used to described bonds that have been downgraded from investment grade to non-investment grade – enter COVID-19 and the collapse of oil prices.

Global corporate bonds historical rating distribution

Source: Bloomberg Barclays Global Aggregate Corporates Index, as at 31 March 2020.

The disruption to economic activity has been staggering with almost all sectors and industries feeling the impact of a global economy at a near standstill. Expectedly, the number of bonds that have actually been downgraded to HY and the number that currently have a rating of BBB-, the last notch within IG, have both risen dramatically as ratings agencies assess the impact of the crisis on corporate balance sheets. For instance, S&P has already stripped 21 companies of their investment grade rating since February of this year, the highest such tally since 2015. Simultaneously, the universe of borrowers it has rated BBB- with a negative outlook (potential fallen angels) currently stands at 96, the highest since March 2009.

While European and US corporate issuers have garnered most of the attention in regards to fallen angels, developments in other areas especially in the Emerging Markets – and to a smaller extent – developed Asia, all point to rising downgrade risks. South Africa's loss of its only remaining investment grade rating last month and Mexico's recent downgrade to BBB- by one of the three major agencies both have significant ramifications for the corporates and quasi-sovereigns in those economies.

In this commentary we share a number of key findings from a recent study conducted by our credit research team on the par amount of likely fallen angels across Europe and the US in the next three to six months. We then examine the impact of these potential downgrades on credit markets and conclude with our outlook and positioning.

Fixed income outlook Fallen angels – What is UBS-AM's view?

To better understand the impact and the risks associated with fallen angels, UBS-AM credit analysts recently conducted an independent assessment of the US and European corporate bond markets. We summarize their expectations for ratings downgrades in the next three to six months as follows:

  • US IG market value: 292 billion across 63 issuers
  • EUR IG market value: 141 billion across 27 issuers

After further reviewing the results we made two major observations regarding the types of risks faced by high-grade borrowers:

  • Direct risks – These are issuers in industries affected by quarantine measures, such as airlines and transportation services
  • Second order risks – These are borrowers in sectors which could suffer in a scenario of rising unemployment, lower consumer confidence and falling business investment spending such as automotive.

US IG fallen angels forecast (USD billions)

Note: This does not constitute a guarantee by UBS AG, Asset Management. Data as at 31 March 2020. Analysis conducted on BBB and BBB- rated bonds.

EUR IG fallen angels forecast (EUR billions)

Note: This does not constitute a guarantee by UBS AG, Asset Management. Data as at 31 March 2020. Analysis conducted on BBB and BBB- rated bonds.

The above estimates are not dissimilar to what the broader market expects. However, the situation remains fluid and dependent on several exogenous factors such as the length of lockdowns imposed in various countries and the nature of any potential exit paths. We will therefore continue to reassess market conditions and update our forecasts as the current environment evolves.

Fixed income outlook What is the impact on credit markets?

Investment Grade

Many fallen angel candidates are already trading at HY levels. For example, at the end of March our expected fallen angels for Europe were trading at 460bps, broadly in line with HY bonds rated BB+/BB. This is in stark contrast with bonds rated BBB and BBB- which traded 360 bps tighter back in January this year. One notable exception to this trend of spread widening in IG can be observed in the US where trading levels have rebounded meaningfully following the announcement by the US Federal Reserve (Fed) that it would begin buying fallen angels as part of its broad-based measures to support markets. Going forward we expect this intervention to provide a floor to pricing levels for US fallen angels with some nuances across sectors.

Compared to the global financial crisis (GFC), the fiscal and monetary support programs being enacted by central banks in response to the current challenges are helping restore order to credit markets. It is also worth noting that banks are healthier today than they were back in the GFC. They have stronger capital and liquidity buffers and we therefore expect a significantly lower incidence of downgrades of subordinated bank debt to high yield. Additionally because banks are in better health, compared to 2008/09, they are in a much stronger position to support businesses during these difficult times.

High Yield

Whilst the absolute amount of fallen angels in Europe is forecasted to be lower than in the US, when compared to the size of the respective HY markets, Europe is expected to feel a heavier impact from downgrades. Based on our analysis the EUR HY market is expected to incur an increase in size of close to 50%. This compares to an increase of just over 25% in the US HY universe.
 

Top sectors in the US most impacted by rating downgrades to HY 

Note: This does not constitute a guarantee by UBS AG, Asset Management. Data as at 31 March 2020. Analysis conducted on BBB and BBB- rated bonds. Forecast weight includes the forecasted fallen angels.

Top sectors in Europe most impacted by rating downgrades to HY

Note: This does not constitute a guarantee by UBS AG, Asset Management. Data as at 31 March 2020. Analysis conducted on BBB and BBB- rated bonds. Forecast weight includes the forecasted fallen angels.

Singapore Retail Investors

PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY BEFORE PROCEEDING. BY UTILIZING THE WEBSITE AND PAGES THEREOF LOCATED AT WWW.UBS.COM/AM-SG ("WEBSITE"), YOU ACKNOWLEDGE THAT YOU HAVE READ THESE TERMS AS WELL AS THE GLOBAL TERMS OF USE (collectively "TERMS") AND THAT YOU AGREE TO BE BOUND BY THEM. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, YOU ARE NOT AN AUTHORIZED USER OF THESE SERVICES AND YOU SHOULD NOT USE THIS WEBSITE.

This website is not intended for and should not be accessed by persons located or resident in any jurisdiction where (by reason of that person's nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirements in such jurisdictions. It is your responsibility to be aware of, to obtain all relevant regulatory approvals, licenses, verifications and/or registrations under, and to observe all applicable laws and regulations of any relevant jurisdiction in connection with your entrance to this website. Each investment product and service referred to on this website is intended to be made available only to residents in Singapore.

UBS reserves the right to change, modify, add or remove content on the website as well as these terms at any time for any reason without notice. Such changes shall be effective immediately upon posting. You acknowledge that by accessing our website after we have posted changes to these terms, you are agreeing to these terms as modified.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289 of Singapore). UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy. UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2020 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

Reset

Fixed income outlook Credit downgrades have happened during past crisis

While the incidence of fallen angels is likely to be elevated in the current environment, the phenomenon of wide-spread downgrades from IG to HY is not without precedence. Similar occurrences took place during the global financial crisis, the Eurozone sovereign crisis and in the oil price collapse of 2014/15. On each of those occasions the market absorbed the supply of those companies that were deemed as being of a higher quality relative to the other downgraded with support bids coming from both dedicated HY investors and cross-over IG investors. Additionally, more recent episodes of downgrades were supported by favorable technical factors such as central bank intervention and yield hungry investors.

Key to this will be a balance between supply and demand for high yield credit. Factors supporting a balance are:

  • we forecast supply to be lower versus previous years as many issuers have already extended their maturity profiles and current uncertainty will discourage opportunistic refinancings 
  • investors have substantial coupon income to be reinvested
  • an expected improvement in the quality of the HY universe generally due to BB rated fallen angels entering the universe and deeply distressed default candidates leaving

As previously mentioned, a key support to the US HY market is the commitment of the Fed to buy fallen angels. With regards to other markets, further intervention from central banks cannot be ruled out due to the unprecedented nature of the crisis. However, it is important to note that there will be some nuances with regards to sectors. We expect those with signficant downgrades to take more time to digest and consequently exhibit higher spread volatility.

Despite the sheer magnitude of expected fallen angels, we believe they will likely be absorbed by the market over the medium to long-term.

What are we doing in light of these findings?

Based on the analysis undertaken by our credit research team we conclude that while the road ahead will be a bumpy one it could also offer attractive opportunities for us to deploy capital on a select basis.

Specifically, we see value in:

  • US IG and EUR IG as these are segments of the market which are supported by direct central bank bond purchase programs and valuations appear attractive
  • Prefer short-duration US HY based on Fed HY ETF purchases with a bias towards the higher-quality segment of the market that benefits directly from Fed bond purchases. Additionally, Asia HY based on China property companies receiving government support

Subscribe now

Perspectives matter. Tune in to our insights.

Through these challenging periods, what remains unwavering is our commitment to active management of bond portfolios and the reliance on strong bottom-up fundamental credit research coupled with forward-looking macro insights to generate the best possible risk-adjusted return outcomes for clients.

More insights